YouTube recommendations have always worked like a one-way mirror. The system first watches your clicks to figure out what you ...
Humana executives gave investors a peek Wednesday into the company's thinking around the 2027 Medicare Advantage bid cycle as elevated costs continue to sting the industry. CEO Jim Rechtin said during ...
UnitedHealth (UNH) stock has rallied on strong Q1 earnings: a $7.23 EPS beat $6.57 consensus, and 2026 guidance raised to $18.25+. UnitedHealth’s Optum diversification cushions against Medicare ...
Humana Inc. (NYSE: HUM) will release its financial results for the first quarter 2026 (1Q26), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on April 29, 2026. The ...
RICHMOND, Ky. (WKYT) - Humana is investing $125,000 into Eastern Kentucky University’s School of Nursing to fund scholarships for students and support for faculty as the commonwealth faces a nursing ...
LOUISVILLE, Ky.--(BUSINESS WIRE)-- Humana Inc. (HUM) announced today that Jim Rechtin, President and Chief Executive Officer, and Celeste Mellet, Chief Financial Officer, will make a presentation to ...
In this episode, Alex Ding, MD, Enterprise Deputy Chief Medical Officer at Humana, discusses the findings from Humana’s latest Value-Based Care Report, including lower hospital admissions and ...
Tara covers the business of health care. Her stories focus on hospitals, doctors, and how their business practices affect patients — especially when private equity gets involved. She also writes about ...
LOUISVILLE, Ky.--(BUSINESS WIRE)-- Humana Inc. (NYSE: HUM) will release its financial results for the fourth quarter 2025 (4Q25), as well as prepared management remarks (in PDF format), at 6:00 a.m.
Despite robust 10-year revenue growth rate (9.17%), HUM's margins have declined due to rising policy benefits, high medical loss ratios, and increased utilization post-pandemic. HUM's margin ...
Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Cost Plus Drugs founder Mark Cuban (Center) speaks at the annual Forbes ...